Javid Fazili

Fluvastatin Inhibits Hepatitis C Replication in Humans

Ted Bader, Javid Fazili, Mohammed Madhoun et al. · The American Journal of Gastroenterology · 2008 · 200 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Development and validation of a model to diagnose cirrhosis in patients with hepatitis C

Vivek Kaul, Frank K. Friedenberg, Leonard E. Braitman et al. · The American Journal of Gastroenterology · 2002 · 55 citations

Medicine, Hematology, Internal Medicine +17

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism

Sripathi M. Sureban, Mohammad F. Madhoun, Randal May et al. · Oncotarget · 2015 · 53 citations · Full text

Medicine, Cancer Biology, Oncology +17

Treatment Outcomes of Hepatitis C-Infected Patients in Specialty Clinic vs. Primary Care Physician Clinic: A Comparative Analysis

Taseen Syed, Samid M. Farooqui, Allshine Chen et al. · Gastroenterology Research and Practice · 2019 · 28 citations · Full text

Medicine, Internal Medicine, Gastroenterology +14

A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients

Ted Bader, L Diane Hughes, Javid Fazili et al. · Journal of Viral Hepatitis · 2013 · 25 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15